Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0002081359-26-000008

Chief Scientific Officer sold 3,568 shares at $10.29 ($36,715)

From the SEC's structured data for this filing

Trades in this filing

Lerner Lorena Raquel · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-08-18 Sale : show line 1 in the form −3,568 $10.29 $36,715 27,559 D
Open-market sales · 3,568 sh · avg $10.29 · $36,715
Loading xslF345X06/form4-08202026_040806.xml…